• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Invivyd, Inc. - Common Stock (NQ:IVVD)

1.160 -0.310 (-21.09%)
Streaming Delayed Price Updated: 3:47 PM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,910,161
Open 1.320
Bid (Size) 1.160 (7,500)
Ask (Size) 1.170 (13,000)
Prev. Close 1.470
Today's Range 1.110 - 1.320
52wk Range 0.4830 - 3.070
Shares Outstanding 109,755,624
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Invivyd (IVVD) Q1 2026 Earnings Transcript ↗
Today 14:47 EDT
Invivyd (IVVD) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Invivyd Q1 Earnings Call Highlights ↗
Today 12:15 EDT
Invivyd (NASDAQ:IVVD) said its first quarter of 2026 was marked by continued progress in its pivotal COVID-19 antibody program, year-over-year growth for PEMGARDA and elevated clinical spending tied to... 
Via MarketBeat
Topics Earnings

Performance

YTD
-53.6%
-53.6%
1 Month
-32.6%
-32.6%
3 Month
-28.0%
-28.0%
6 Month
-34.5%
-34.5%
1 Year
+34.7%
+34.7%

More News

Read More
Invivyd (NASDAQ:IVVD) Q1 Miss Sends Shares Lower as PEMGARDA Revenue Falls Short and R&D Costs Surge ↗
Today 8:22 EDT
Via Chartmill
News headline image
Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights
Today 7:01 EDT
From Invivyd
Via GlobeNewswire
News headline image
Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination
May 11, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026
May 07, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 05, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit
April 20, 2026
From Invivyd
Via GlobeNewswire
Which stocks are experiencing notable movement on Thursday? ↗
April 09, 2026
Via Chartmill
News headline image
Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles
April 09, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health
April 07, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 06, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd Announces Presentation at the World Vaccine Congress Washington
March 30, 2026
From Invivyd
Via GlobeNewswire
News headline image
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
March 09, 2026
Via Benzinga
Topics Stocks
News headline image
Invivyd (IVVD) Q4 2025 Earnings Call Transcript ↗
March 05, 2026
Via The Motley Fool
Topics Earnings
News headline image
Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates
March 05, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer
March 05, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd to Host Fourth Quarter and Full-Year 2025 Financial Results and Corporate Update Conference Call on March 5, 2026
March 02, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 02, 2026
From Invivyd
Via GlobeNewswire
News headline image
New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies
February 24, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration
February 03, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd Announces Partnership with World Champion Skier Lindsey Vonn to Educate Americans on Antibodies and Disease Prevention
January 22, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd and SPEAR Study Group Announce Plan for Phase 2 Study of VYD2311 for Treatment of Long COVID and COVID Vaccine-Injured Individuals to Commence Mid-2026
January 20, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights
January 08, 2026
From Invivyd
Via GlobeNewswire
News headline image
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
December 23, 2025
From Invivyd
Via GlobeNewswire

Frequently Asked Questions

Is Invivyd, Inc. - Common Stock publicly traded?
Yes, Invivyd, Inc. - Common Stock is publicly traded.
What exchange does Invivyd, Inc. - Common Stock trade on?
Invivyd, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Invivyd, Inc. - Common Stock?
The ticker symbol for Invivyd, Inc. - Common Stock is IVVD on the Nasdaq Stock Market
What is the current price of Invivyd, Inc. - Common Stock?
The current price of Invivyd, Inc. - Common Stock is 1.160
When was Invivyd, Inc. - Common Stock last traded?
The last trade of Invivyd, Inc. - Common Stock was at 05/14/26 03:47 PM ET
What is the market capitalization of Invivyd, Inc. - Common Stock?
The market capitalization of Invivyd, Inc. - Common Stock is 127.32M
How many shares of Invivyd, Inc. - Common Stock are outstanding?
Invivyd, Inc. - Common Stock has 127M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap